Allogeneic Demineralized Dentin Matrix as rhBMP-2 Carrier: A Retrospective Clinical Study.

Area of Science:

• Dental Implantology
• Bone Regeneration
• Biomaterials Science

Background:

• Demineralized dentin matrices (DDM) are utilized in bone regeneration.
• Recombinant human bone morphogenetic protein-2 (rhBMP-2) enhances osteogenesis.
• Autogenous and allogeneic sources of DDM are available for dental applications.

Purpose of the Study:

• To compare clinical outcomes of autogenous demineralized dentin matrices (auto-DDM/rhBMP-2) versus allogeneic demineralized dentin matrices (allo-DDM/rhBMP-2) loaded with rhBMP-2.
• To evaluate buccal marginal bone resorption around dental implants as the primary clinical outcome.

Main Methods:

• Retrospective study comparing auto-DDM/rhBMP-2 (control) and allo-DDM/rhBMP-2 (experimental) groups.
• Buccal marginal bone resorption measured via CBCT at T0, T1, and T2 (post-surgery and 1-2 years post-loading).
• Histologic analysis of bone specimens from both groups.

Main Results:

• No significant difference in buccal marginal bone resorption between auto-DDM/rhBMP-2 and allo-DDM/rhBMP-2 groups at any time point.
• Histologic analysis showed similar osteoinductive potential and new bone formation proportions.
• Bone resorption values at T2 were 0.29 ± 0.45 mm for auto-DDM/rhBMP-2 and 0.20 ± 0.30 mm for allo-DDM/rhBMP-2.

Conclusions:

• Allogeneic demineralized dentin matrices loaded with rhBMP-2 exhibit comparable clinical outcomes to autogenous matrices.
• Allo-DDM/rhBMP-2 is a viable alternative to auto-DDM/rhBMP-2 for dental implant procedures.
• Both materials support bone regeneration with similar efficacy.